Dutch data support continuation over discontinuation of urate-lowering therapy to achieve a serum urate level of 0.36 mmol/L ...

High uric acid is silently rising in India, increasing risks of gout, kidney disease, diabetes, obesity, and heart ...

The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the ...

Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...

Get ready for a deep dive into colchicine and cardiovascular disease! We’ll examine the RCT data, and then pivot to discuss ...

EULAR – The European Alliance of Associations for Rheumatology – held its 2026 annual Congress in London, where gout was high on the agenda. Current guidelines recommend lifelong urate-lowering ...

The chronic gout market is experiencing significant growth driven by rising prevalence due to aging populations and lifestyle changes, notably obesity and urbanization. Improved clinical guidelines ...

Gout Awareness Day is observed annually on May 22 with a goal of educating the public about the disease and bringing awareness is what Salisbury resident Glenn Terry also wants […] ...

One week Niven Hopkins thought he had a sore foot, and the next, he was facing a life-changing diagnosis.

Trying to carry on and going on a Lake District trip away that June in 2026 with what turned out to be gout, he ended up ...

Sobi announces positive topline results from pivotal phase 3 REDUCE 2 study of pozdeutinurad in gout: Stockholm, Sweden Saturday, May 23, 2026, 11:00 Hrs [IST] Sobi, a global biop ...

Crystalys Therapeutics Inc. ('Crystalys' or 'the Company'), a clinical-stage biopharmaceutical company addressing the significant unmet medical needs of people living with gout, today announced that ...